ClinicalTrials.Veeva

Menu

Spectral-domain Optical Coherence Tomography Findings in Retinal Vessel Occlusion

T

Technische Universität Dresden

Status

Enrolling

Conditions

Retinal Ischemia

Treatments

Other: optical coherence tomography

Study type

Observational

Funder types

Other

Identifiers

NCT03061526
EK 417102016

Details and patient eligibility

About

Retinal vessel occlusions might lead to ischemia of the inner retina, more severe so in artery occlusions. Intracellular edema may develop and decrease transparency of those layers, showing retinal edema. In spectral domain optical coherence tomography (SD-OCT) retinal reflectivity changes as a result of retinal edema. The investigators examine the reflectivity changes of different retinal layers between healthy eyes and eyes with retinal artery occlusion and ischemic or non-ischemic vein occlusions. Aim of the study is to evaluate whether those changes can be used to measure the level of ischemia in the inner retina.

Full description

Several studies tried to classify retinal ischemia due to retinal artery or vein occlusion into different grades. In some cases prognosis is dependent on grade of severity, especially in cases of retinal vein occlusion. State of the art to Diagnose the severity of retinal ischemia is lfuorescein angiography. However, this technique is invasive and might cause Problems like anaphylactic shock. Optical coherence tomography is a non-invasive technique, but up to now there is no standardized method to quantify the grade of severity of retinal ischemia in such conditions like retinal vessel occlusion. The study hope to find criteria by which such a classification can be constructed.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute Retinal vessel occlusion on one eye
  • healthy contralateral eye
  • examined with spectral Domain optical coherence tomography

Exclusion criteria

  • retinal occlusion older than 1 week
  • OCT Image not obtainable/missing

Trial contacts and locations

1

Loading...

Central trial contact

Olga Furashova; Egbert Matthé, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems